Study of Rebamipide Eye Drops to Treat Dry Eye

Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00201955
Collaborator
Novartis (Industry)
740
60
26
12.3
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

There is a need for effective therapy for dry eye that treats the underlying cause of the syndrome. The goal of this study is to assess the impact of rebamipide on dry eye symptoms.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 26 Week Study
Study Start Date :
May 1, 2004
Study Completion Date :
Jul 1, 2006

Outcome Measures

Primary Outcome Measures

  1. fluorescein corneal staining (FCS) total score at week 12 and the average primary ocular discomfort (POD) severity score at week 12 []

Secondary Outcome Measures

  1. fluorescein corneal staining (FCS) total score at week 26 and the average primary ocular discomfort (POD) severity score at week 26 []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • must have symptoms of dry eye for a minimum of 6 months

  • must be able to sign and date an informed consent

Exclusion Criteria:
  • presence of anterior segment disease

  • glaucoma or ocular hypertension

  • using Restasis

  • use of topically instilled ocular medications during study

  • use of contact lenses

  • history of ocular surgery within 12 months

  • females who are pregnant, breast feeding, or child-bearing potential and not willing to remain abstinent or use contraception

  • presence of Stevens-Johnson syndrome

  • any anticipated change in medication through-out study

  • concurrent involvement in another study or previous receipt of this drug

  • cannot be safely be weaned off of ocular medications

Contacts and Locations

Locations

Site City State Country Postal Code
1 Harold Helms, MD Birmingham Alabama United States 35205
2 Michael Bernstein, MD Birmingham Alabama United States 35216
3 I Care! Eye Care! Flagstaff Arizona United States 860001
4 Harvey and Bernice Jones Eye Institute Little Rock Arkansas United States 72205
5 United Medical Research Institute Inglewood California United States 90301
6 Benchmark Research San Francisco California United States 94102
7 Southern California Clinical Research, Inc. San Marino California United States 91108
8 Colorado Eye Associates, PC Colorado Springs Colorado United States 80907
9 Danbury Eye Physicians and Surgeons, P.C. Danbury Connecticut United States 06810-4005
10 Florida Ophthalmic Institute Gainesville Florida United States 32605-3192
11 Florida Wellcare Alliance, L.C. Inverness Florida United States 34452
12 Shettle Eye Center Largo Florida United States 33770
13 Suncoast Clinical Research, Inc. New Port Richey Florida United States 34652
14 Tukio Institute for Clinical Research North Miami Beach Florida United States 33169
15 Magnolia Research Group, Inc. Ocala Florida United States 34471
16 Radiant Research - West Palm Beach West Palm Beach Florida United States 33407
17 Vision Incorporated Savannah Georgia United States 31406
18 Welborn Clinic Evansville Indiana United States 47714
19 Heartland Research Associates, LLC Wichita Kansas United States 67207
20 Wichita Clinic, PA Wichita Kansas United States 67208
21 Taustine Eye Center Louisville Kentucky United States 40217
22 Bossier Optical, Inc. Bossier Louisiana United States 71111
23 Stevenson Medical Surgical Eye Center New Orleans Louisiana United States 70119
24 Family Eye Centers New Orleans Louisiana United States 70127
25 Ophthalmic Research Associates, Inc. N. Andover Massachusetts United States 01845
26 Minnesota Eye Associates Minneapolis Minnesota United States 55404
27 Depremont Eye Specialists Gulfport Mississippi United States 39507
28 Opthalmology Associates Creve Coeur Missouri United States 63141
29 Clinical Research Laboratories Piscataway New Jersey United States 08854
30 Ophthalmology Associates Princeton New Jersey United States 08540
31 Eye Care Associates Bethpage New York United States 11021
32 Ophthmalmic Consultants of Long Island Lynbrook New York United States 11563
33 Mt. Sinai Medical Center School of Medicine New York New York United States 10029
34 Rochester Ophthalmological Group Rochester New York United States 14618
35 Ophthalmic Consultants of Long Island Rockville Center New York United States 11570
36 Ophthalmic Consultants of Long Island Valley Stream New York United States 11581
37 Western Wake Eye Center, P.A. Cary North Carolina United States 27511
38 Southeast Clinical Research Associates Charlotte North Carolina United States 28210
39 Horizon Eye Care - Clinical Research Dept. Charlotte North Carolina United States 28211
40 Cornerstone Research Care High Point North Carolina United States 27262
41 Carolina Eye Associates Southern Pines North Carolina United States 28387
42 Cincinnati Eye Institute Cincinnati Ohio United States 45242
43 Comprehensive Opthalmology & Optical Services Cleveland Ohio United States 44115
44 Bend Medical Clinic Bend Oregon United States 97701
45 Medical Eye Center Medford Oregon United States 97504
46 Valley Clinical Research Center Easton Pennsylvania United States 18045
47 Philadelphia Eye Associates Philadelphia Pennsylvania United States 19148
48 Glaucome-Cataract Consultants Pittsburgh Pennsylvania United States 15243
49 University of Pittsburg Eye and Ear Institute Pittsburg Pennsylvania United States 15233
50 Black Hills Regional Eye Institute Rapid City South Dakota United States 57701
51 Total Eye Care, P.A. Memphis Tennessee United States 38119
52 Corona Research Consultants, Inc. El Paso Texas United States 79904
53 The University of Texas Medical Branch Galveston Texas United States 77555
54 Physician Research Network Houston Texas United States 77002
55 Houston Texas United States 77002
56 Medical Center Ophthalmology Houston Texas United States 77030
57 Houston Eye Associates Houston Texas United States 77125
58 Sun Research Institute San Antonio Texas United States 78205
59 Eye Clinic of South Texas San Antonio Texas United States 78209
60 Advanced Healthcare Clinical Research Center Milwaukee Wisconsin United States 21209

Sponsors and Collaborators

  • Otsuka Pharmaceutical Development & Commercialization, Inc.
  • Novartis

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00201955
Other Study ID Numbers:
  • 37E-03-201
First Posted:
Sep 20, 2005
Last Update Posted:
Nov 2, 2006
Last Verified:
Oct 1, 2006

Study Results

No Results Posted as of Nov 2, 2006